drugset / Trial / NCT00489606

Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530

NCT00489606

Phase 1 Completed 16 enrolled SK Chemicals Co., Ltd.
RandomizedCrossoverDouble-blindTreatment

Summary

To assess the pharamcodynamic effects of coadministrated SK3530(PDE5 inhibitor) and tamsulosin, phase I study in healthy volunteers was designed.

Timeline

Start
2007-04
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirodenafil Small molecule 100 mg Oral

Indications